Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) Q3 2019 Earnings Conference Call November 14, 2019 4:30 PM ET Company Participants Matt Clawson - Investor Relations, Practice Leader and Investor Relations at W2O Group Raymond Cohen - Chief Executive Officer Dan Dearen - President & Chief Financial Officer Karen Noblett - Chief Medical Officer Conference Call Participants Larry Biegelsen - Wells Fargo Securities Danielle Antalffy - SVB Leerink LLC Adam Maeder - Piper Jaffray David Lewis - Morgan Stanley ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-Q _________________________________________________________________ (Mark One) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to _______ ...

Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) Q2 2019 Results Earnings Conference Call August 5, 2019 4:30 PM ET Company Participants Matt Clawson - Investor Relations, Practice Leader and Investor Relations at W2O Group Raymond Cohen - Chief Executive Officer Dan Dearen - President & Chief Financial Officer Karen Noblett - Chief Medical Officer Conference Call Participants Bob Hopkins - Bank of America Larry Biegelsen - Wells Fargo Marissa Bych - Morgan Stanley Operator Good afternoon, ladies and gen ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-Q _________________________________________________________________ (Mark One) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ ...

Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Jill Bertotti – W2O Group Ray Cohen – Chief Executive Officer Dan Dearen – President and Chief Financial Officer Conference Call Participants Travis Steed – Bank of America David Lewis – Morgan Stanley Bruce Nudell – SunTrust Operator Good afternoon, ladies and gentlemen, and welcome to the Axonics First Quarter 2019 Results Conference Call. At this time all participants are in a ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-Q _________________________________________________________________ (Mark One) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ ...

Axonics Modulation Technologies (NASDAQ:AXNX) Q4 2018 Earnings Conference Call March 5, 2019 4:30 PM ET Company Participants Matt Clawson - W2O Group, Investor Relations Ray Cohen - Chief Executive Officer Dan Dearen - President & Chief Financial Officer Karen Noblett - Chief Medical Officer Conference Call Participants Varun Kuchibhatla - Morgan Stanley Tyler Knisley - SunTrust Operator Good day, ladies and gentlemen, and welcome to the Axonics Fourth Quarter and Year-End 2018 Results Conference Call. At t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-K _________________________________________________________________ (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Comm ...